(b)(4).Report source, foreign: event occurred in (b)(6).The device was not returned to the manufacturer.Therefore it could not be analyzed.The review of the device manufacturing quality record indicates that 694 products endobon xenograft granules 0.5ml, reference (b)(4) batch u0153300 were manufactured on 12 november 2014.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
|
(b)(4).This follow-up report is being submitted to relay additional information and correction.The following section has been updated : b3, b4, b5, e1, e3, g4, h2, h6 and h10.The product analysis can't be performed as the product was not returned.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.A complaint extract was done regarding non integration: - 10 complaints have been recorded on endobon xenograft granules 0.5ml, reference (b)(4), from 1 (b)(6) 2020.- 1 complaint has been recorded on endobon xenograft granules 0.5ml, reference (b)(4), batch u0153300.According to available data, the root cause of the event can¿t be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
|